Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES
Bio-Rad Diabetes Division

Microfluidic Silicon Probe Accurately Stains Tissue Sections

By Labmedica International staff writers
Posted on 24 Jan 2012
Image: The probe consists of a silicon microfluidic head having two microchannels. Unlike an inkjet printer cartridge, the head reaspirates the liquid that it injects on a surface. This prevents spreading and accumulation of the liquid on the surface, which can lead to overexposure (Photo courtesy of IBM).
Image: The probe consists of a silicon microfluidic head having two microchannels. Unlike an inkjet printer cartridge, the head reaspirates the liquid that it injects on a surface. This prevents spreading and accumulation of the liquid on the surface, which can lead to overexposure (Photo courtesy of IBM).
A flexible, noncontact microfluidic probe made from silicon can help pathologists to investigate critical tissue samples for disease diagnostics.

The microfluidic probe can accurately stain tissue sections at the micrometer scale. It consists of a silicon microfluidic head having two microchannels. Unlike an inkjet printer cartridge, the head reaspirates the liquid that it injects on a surface. This prevents spreading and accumulation of the liquid on the surface, which can lead to overexposure.

Specifically for tissue section analysis, the probe can deliver an antibody very locally in a selected area of a tissue section with pinpoint accuracy. Since analysis can be done on spots and lines instead of on the entire tissue section, the tissue is better preserved for additional tests, if required. In addition, only a few picoliters of liquid containing antibodies are needed for each analysis spot.

IBM (Zurich, Switzerland) scientists developed the microfluidic probe, which fits to standard workflows in conventional pathology. In addition, it is compatible with current biochemical staining systems and resistant to a broad range of chemicals. The small size of the probe also enables easy viewing of the sample from above and below by the inverted microscope commonly used in clinical laboratories.

"We have developed a proof-of-concept technology, which I hope puts pathology on a modern roadmap—benefiting from the latest developments in silicon-based microfluidics," said Govind Kaigala, a scientist at IBM Research-Zurich. He added, "This new approach will enable pathologists to stain tissue samples with micrometer precision and easily perform multiple tissue stains on limited samples."

IBM scientists will continue to test and improve the microfluidic probe and potentially begin using it in laboratory environments in the next several months. In addition, the team plans to explore specific clinical applications, possibly with partners in the field of pathology. The microfluidic probe promises to support the work of pathologists and become a tool of choice for pharmaceutical research and diagnostics involving biological specimens.

Related Links:

IBM Research, Zurich



KARL HECHT GMBH & CO KG
DIASYS DIAGNOSTIC SYSTEMS
77 ELEKTRONIKA

Channels

Hematology

view channel

Magnetic Resonance Improves Approach to Measuring Hemostasis Parameters

Two studies evaluating a magnetic resonance based detector for hemostasis measurements found its multiplex results to be rapid and accurate using lower blood volumes. At the International Society on Thrombosis and Hemostasis (ISTH) 2015 Congress (Toronto, Canada), T2 Biosystems, Inc. (Lexington, MA, USA) presented results... Read more

Lab Tech.

view channel
Image: Verigene System instrumentation consists of a Verigene Reader and one or multiple Verigene Processor SPs (Photo courtesy of Nanosphere).

Directed Molecular Diagnostic Tests Highlight Recent Microbiology Conference

The performance of a series of directed molecular diagnostic tests was confirmed by several studies presented at a recent microbiology conference. Nanosphere (Northbrook, IL, USA) manufactures tests... Read more

Industry News

view channel

QIAGEN Expands Diagnostics Menu in Partnership with Seegene

In a new collaboration, Seegene Inc. (Soul, Republic of Korea) will use its proprietary next-generation qPCR technology in developing new multiplex assays for the flagship platform of Qiagen NV (Venlo, Netherlands and Hilden, Germany). Seegene will develop a menu of multiplex assay panels for the modular QIAsymphony... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.